Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Pharmacogenet Genomics. 2021 Sep 1;31(7):146–154. doi: 10.1097/FPC.0000000000000434

Table 3:

Prevalence of SNP mutant alleles in study sample population, and compared to prevalence from the 1000 Genomes Project

SNP Study Count Study Prevalence 1K Genomes AF for AFR* 1K Genomes AF for AMR*
rs7037276 52 96.3% 94% 95%
rs1042714 51 94.4% 86% 76%
rs892940 51 94.4% 82% 50%
rs2626393 49 90.7% 74% 58%
rs2781659 45 83.3% 71% 55%
rs7081864 45 83.3% 67% 33%
rs7903366 45 83.3% 66% 33%
rs2248119 44 81.5% 49% 22%
rs1042713 43 79.6% 52% 46%
rs295137 41 75.9% 51% 28%
rs1342326 32 59.3% 35% 14%
rs7070958 29 53.7% 67% 33%
rs28450894 16 29.6% 16% 4%
rs912142 16 29.6% 52% 22%
rs13090972 14 25.9% 20% 38%
rs9507294 13 24.1% 10% 62%
rs9551086 9 16.7% 5% 58%
rs7041938 4 7.4% 4% 16%
rs9553225 4 7.4% 2% 46%
rs958144 4 7.4% 2% 33%
rs73650726 3 5.6% 9% 1%

Highlighted SNPs discussed in the text

AFR = African, AMR = American